Lenalid 25mg Capsule contains Lenalidomide, a prescription medicine used to treat certain types of blood cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Composition | Lenalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Expiry | December 2027 |
Xapavir 50mg Tablet contains Dolutegravir, an antiretroviral medication used in the treatment of HIV-1 infection. It belongs to the class of drugs known as integrase strand transfer inhibitors (INSTIs).
| Composition | Dolutegravir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Bracanat 150 mg Tablet is an oral anticancer medicine containing Olaparib, used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. It works by blocking cancer cell DNA repair, helping slow disease progression.
| Composition | Olaparib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | Ovarian and Breast Cancer |
| Expiry | December 2027 |
Ibrunat 140mg Capsule contains Ibrutinib, a targeted cancer therapy used to treat certain blood cancers such as Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM).
| Composition | Ibrutinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Blood Cancers |
| Expiry | December 2027 |
Lenvat 10mg Capsule contains Lenvatinib, a targeted therapy used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Natdac 60mg Tablet contains Daclatasvir, a direct-acting antiviral medication used in combination with other drugs for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Daclatasvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Pomalid 2mg Capsule contains Pomalidomide, an immunomodulatory drug used in the treatment of multiple myeloma (a type of blood cancer), especially in patients who have not responded to other therapies such as lenalidomide and bortezomib.
| Composition | Pomalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 21 Capsules in 1 Bottle |
| Prescribed For | Multiple Myeloma |
| Expiry | December 2027 |
Regonat 40 mg Tablet contains Regorafenib, a targeted chemotherapy medicine used to treat certain types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets in 1 Bottle |
| Prescribed For | Colorectal Cancer, Liver Cancer and GIST |
| Expiry | December 2027 |
Sutinat 50mg Capsule is an oral anti-cancer medication that contains Sunitinib Malate, a targeted therapy used to treat certain advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Tipanat 20 is an oral chemotherapy medication used in the treatment of advanced or metastatic colorectal cancer and gastric (stomach) cancer. It contains a combination of Trifluridine (antineoplastic agent) and Tipiracil (a thymidine phosphorylase inhibitor).
| Composition | Tipiracil (8.19mg) + Trifluridine (20mg) |
| Manufacturer | Natco Pharma Ltd |
| Packing | 20 Tablets in 1 Bottle |
| Prescribed For | Stomach Cancer |
| Expiry | December 2027 |
Zoldonat 4 mg Injection contains zoledronic acid and is used to treat high blood calcium levels caused by cancer, prevent bone complications in cancers like breast or prostate cancer, and manage conditions such as osteoporosis and Paget’s disease.
| Composition | Zoledronic Acid |
| Manufacturer | Natco Pharma Ltd |
| Packing | 1 Injection in 1 vial |
| Prescribed For | Osteoporosis |
| Expiry | December 2027 |
Hepcinat 400 mg contains Sofosbuvir and is used to treat chronic Hepatitis C virus (HCV) infection in adults and children (aged 3 and above).
| Composition | Sofosbuvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Geftinat 250mg Tablet contains Gefitinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC), especially in patients with EGFR gene mutations.
| Composition | Gefitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Cazanat 60mg contains Cabozantinib, a targeted therapy used in the treatment of certain types of cancers, including advanced kidney cancer (renal cell carcinoma) and liver cancer (hepatocellular carcinoma).
| Composition | Cabozantinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets |
| Prescribed For | Kidney and Liver Cancer |
| Expiry | December 2027 |
Capnat 500mg tablet contains Capecitabine, a chemotherapy medicine used to treat several cancers, including breast cancer, colon cancer, and rectal cancer.
| Composition | Capecitabine |
| Manufacturer | Natco Pharma Ltd |
| Packing | 100 Tablets |
| Prescribed For | Breast, Colon, Rectal Cancer |
| Expiry | December 2027 |
Apnat 60mg Tablet contains Apalutamide, an anti-androgen medication used in the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).
| Composition | Apalutamide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 120 Tablets |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Afanat 40mg contains Afatinib, a targeted cancer therapy used to treat non-small cell lung cancer (NSCLC) that is EGFR mutation-positive.
| Composition | Afatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
